What Could Push NVDA Stock Higher From Here?

While the world focuses on its GPU dominance, the company is mounting a surprise attack on an entirely new market. It is now targeting the CPU space, a category it has never addressed before. This move opens a brand new addressable market, altering the company’s growth profile.

This is not a pivot from strength but an addition to it. The core data center business continues to compound at a staggering rate. The upside case rests on layering this new revenue stream onto that massive, high-growth base.

That’s the story. The cleanest way to interrogate it is to break the 3-year stock move in NVIDIA (NVDA) into the three things that can drive it: revenue compounding, net margin trajectory, and the multiple itself. Then look at which one is doing the heavy lifting under conservative assumptions.

The Three Levers Of Upside

Today’s price is paying for some combination of these three. Under our conservative calibration:

1. Revenue compounding at 30% annually. Top line moves from $253.5B to $556.9B. Standalone contribution to the price move: 120%.
2. Net margin eases from 63% to 60%. Standalone contribution: -5.5%.
3. P/E multiple compresses further from 30.0x to 22.5x as a slower forward growth rate no longer supports today’s multiple, even though it already sits below its 3-year average. Standalone contribution: -25%.

Multiplied through, the three combine to roughly 56% of upside over three years. Before we stress each one, here is the picture they are operating on top of:

*LTM: Last Twelve Months

What Happens To Upside If The Levers Change?

The base case lands at 56%. Soften revenue compounding by 200 basis points, so the top line grows at 28% instead of 30%, and the upside slides toward 49%. Let net margin give back to the 3-year average of 52%, below the 60% the base case holds, and it lands closer to 35%. The multiple is the most powerful lever in the other direction: hold it flat at today’s 30.0x rather than letting it compress as the base case assumes, and the upside actually climbs to 108%. That gap is what the multiple compressions are costing the case. And stretching the horizon from 3 years to 5 lifts the upside to 163%, with the math compounding in the patient investor’s favor.

What Could Tilt The Levers Higher

The new Vera CPU is the key catalyst, arriving just in time for an inflection in agentic AI. The company already has visibility to nearly $20 billion in total CPU revenue this year. This product line represents a material addition to the top line.

What Could Break The Combination

The primary risk is uncertainty around the next major product cycle. When asked about the upcoming VeraRubin ramp, management conceded it is hard to say what the pace will be. This ambiguity about the slope of the next growth wave remains an open question.

Which Lever Carries The Weight

Of the three levers, revenue compounding is doing the most. Margins and the multiple are supporting actors that can chip in or chip away, but the case lives or dies on the top line moving at roughly the projected pace.

Near-term revenue from Vera CPUs is concrete, while uncertainty over the VeraRubin ramp seems a question of timing, not trajectory.

Should You Invest In NVIDIA?

For a different read on NVDA, see our recent piece How Much Upside Can NVDA Stock’s Growth Deliver?

A careful 3-year case on a single name is still a concentrated bet, as historical volatility across past market crises shows. Investors who build analyses like this on individual positions often want the same framework running across a diversified book, partly for discipline, partly because even the cleanest single-stock thesis can break for reasons the math does not capture.

If it is exposure to technology as a whole you want rather than this one name, a technology ETF like VGT covers that single sector. Going broader than any one sector, to a quality-first mix across the whole market, is where the portfolio below comes in.

The Trefis High Quality (HQ) Portfolio combines analytical rigor with a forward-looking view across 30 stocks, with a consistent selection framework and a sizing and re-balancing discipline designed to deliver upside without the single-name risk you just read through here.

By selecting 30 high-conviction stocks, the HQ strategy has historically outpaced a benchmark that combines the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000.